Caladrius Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

NEXT STORY
Cellectis to Hold Fourth Quarter 2020 Earnings Call on Friday, March 5, 2021 at 8:00AM EST
PREV STORY
TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Sunesis to Host Conference Call on July 29th to Discuss Second Quarter 2016 Financial Results and Recent Highlights

SOUTH SAN FRANCISCO, Calif., July 21, 2016 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) ...

author_avatar
NASDAQ Market News

Servier licenses GLPG1972 in osteoarthritis from Galapagos

Mechelen, Belgium; Suresnes Cedex, France; 27 July 2017, 22.00 CET, regulated information - As ...

author_avatar
NASDAQ Market News

Motif Bio to Present Iclaprim Data at ECCMID 2018

Phase 3 trial results for REVIVE-2 in patients with ABSSSIPotential cost savings opportunities with ...

author_avatar
NASDAQ Market News